An observational study in Hepatitis C, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-05-15.
Sponsored by US Department of Veterans Affairs · Observational
Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.
Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.
2,709 studies on the registry are indexed under Hepatitis A; 142 are open to participants now.
This study's enrollment of 21 is below the median of 250 across 687 observational studies indexed under Hepatitis A.
Browse Hepatitis A studies →US Department of Veterans Affairs is the lead sponsor of 658 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
VHA patients who ever initiated antiviral treatment for hepatitis C.
Ever initiated anitiviral treatment for hepatitis C.
Exclusion Criteria:
none
patients who initiated antiviral treatment for hepatitis C
Attributes of Treatment Experience
Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
Time frame: Zero to five years since ending treatment.
| Milestone | Group 1 |
|---|---|
| Started | 21 |
| Completed | 21 |
| Not completed | 0 |
Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
| participants | Group 1 |
|---|---|
| Avoid Bad End | 14 |
| Perseverence | 15 |
| Achieve Cure | 7 |
| Redemption | 9 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Group 1 | — | 0/21 (0%) | 0/21 (0%) |
patients who initiated antiviral treatment
| Age, Continuous(years) | Group 1 |
|---|---|
| Mean | 57 (50 to 69) |
| Age, Categorical(Participants) | Group 1 |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 20 |
| >=65 years | 1 |
| Sex: Female, Male(Participants) | Group 1 |
|---|---|
| Female | 1 |
| Male | 20 |
| Region of Enrollment(participants) | Group 1 |
|---|---|
| United States | 21 |
This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
US Department of Veterans Affairs